Ofran Injection

Ofran 2 mg/ml Injection সম্পর্কে

বাংলাদেশে Ofran 2 mg/ml Injection ইনজেকশন হিসেবে পাওয়া যায়; এতে Ondansetron আছে (২ mg/ml)। এটি তৈরি করে Square Pharmaceuticals PLC। Ondansetron-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।

Ondansetron-এর ৭৪টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Periset 16 mg Suppository-এর, প্রতি ইউনিট ৳ ১।

Ofran 2 mg/ml Injection কী?

Ofran Injection is a medicine that contains ondansetron, which belongs to a group called anti-emetics. It works by blocking a natural substance in the body that triggers the vomiting reflex. Doctors use it to prevent nausea and vomiting caused by cancer chemotherapy or radiotherapy, and to prevent and treat nausea and vomiting after surgery. The injection is given by a healthcare professional, usually in a hospital or clinic setting. The dose and course are decided by the doctor based on the patient's condition.

Ofran-এর ব্যবহার

Ofran Injection is used to prevent nausea and vomiting that can occur with cancer chemotherapy or radiotherapy. It is also used to prevent and treat nausea and vomiting after surgery. It is not a general treatment for all types of nausea and vomiting; a doctor will decide if it is appropriate.

Ofran কীভাবে ব্যবহার করবেন

Ofran Injection is given by a doctor or nurse, usually as an intravenous infusion. The dose and how often it is given are decided by the doctor, who will consider the patient's age, weight, and the reason for treatment. Do not attempt to use this medicine yourself. Always follow the instructions of your healthcare team.

Ofran-এর পার্শ্বপ্রতিক্রিয়া

Common side effects of ondansetron include headache, constipation, and diarrhea. Most are mild or moderate. Other side effects may occur, such as a feeling of warmth or flushing, hiccups, or changes in liver enzymes. Rarely, serious allergic reactions, breathing problems, or chest pain have been reported. Tell your doctor if you notice any side effects.

সতর্কতা ও নিরাপত্তা

Before using Ofran Injection, tell your doctor if you are allergic to ondansetron or similar medicines, or if you have liver problems. It should not be used with apomorphine. The safety of ondansetron in pregnancy is not fully established; discuss with your doctor if you are pregnant, planning pregnancy, or breastfeeding. The doctor will decide if it is suitable for you. Store as directed by the healthcare provider.

সাধারণ প্রশ্ন

How is Ofran Injection taken?

Ofran Injection is given by a healthcare professional, usually as an intravenous infusion. The dose and frequency are decided by the doctor based on your condition. Do not try to inject it yourself.

What is Ofran Injection used for and what kind of medicine is it?

Ofran Injection is an anti-emetic medicine. It is used to prevent nausea and vomiting caused by chemotherapy or radiotherapy, and to prevent and treat nausea and vomiting after surgery.

What does the strength and dosage form mean?

The strength of 2 mg/ml means each millilitre of the injection contains 2 milligrams of ondansetron. The dosage form is an injection, which is given by a healthcare professional.

Who should not receive Ofran Injection?

People allergic to ondansetron or any ingredient should not receive it. It should not be used with apomorphine. Tell your doctor about allergies, liver problems, pregnancy, or breastfeeding before treatment.

নির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Ondansetron is a serotonin subtype 3 (5-HT3) receptor antagonist indicated:
  • Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
  • Prevention and treatment of post-operative nausea and vomiting.
  • Prevention of radiotherapy-induced nausea and vomiting.

ফার্মাকোলজি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Ondansetron is a potent, highly selective 5HT3 receptor-antagonist. Its precise mode of action in the control of nausea and vomiting is not known. Chemotherapeutic agents and radiotherapy may cause release of 5HT in the small intestine initiating a vomiting reflex by activating vagal afferents via 5HT3 receptors. Ondansetron blocks the initiation of this reflex. Activation of vagal afferents may also cause a release of 5HT in the area postrema, located on the floor of the fourth ventricle, and this may also promote emesis through a central mechanism. Thus, the effect of ondansetron in the management of the nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy is probably due to antagonism of 5HT3 receptors on neurons located both in the peripheral and central nervous system. The mechanisms of action in post-operative nausea and vomiting are not known but there may be common pathways with cytotoxic induced nausea and vomiting.

মাত্রা ও সেবনবিধি

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Chemotherapy-Induced Nausea and Vomiting-
Adults, Pediatric patients (6 months to 18 years):
  • 8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
  • 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
  • Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Radiotherapy-Induced Nausea and Vomiting-
Adults:
  • 8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
  • 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
  • Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Postoperative Nausea and Vomiting-
Adults:
  • 8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
  • 4 mg orodispersible tablet: 16 mg
  • Injection: 4 mg
Pediatrics (>40 kg): Injection: 4 mg
Pediatrics (40 kg): Injection: 0.1 mg/kg

Chemotherapy-induced Nausea and Vomiting-
Adults/Geriatric/Child of 12 years or over:
  • Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
  • Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Pediatric (4-11 years): 5 ml (4 mg) Ondansetron Oral Solution should be taken 30 minutes before the start of chemotherapy. The other 2 doses should be taken 4 and 8 hours after the first dose. Then 5 ml oral solution should be administered 3 times a day (every 8 hours) for 1-2 days after completion of chemotherapy.


Oral solution:

Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):
  • The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
  • For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
  • For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
  • For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
Postoperative Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):
  • 20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia


Oral Soluble Film:

Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:
  • Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
Prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy:
  • Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
  • Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
  • Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
  • Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.

ঔষধের মিথষ্ক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Ondansetron does not itself appear to induce or inhibit the cytochrome P-450 drug-metabolizing enzyme system of the liver. Because Ondansetron is metabolized by hepatic cytochrome P-450 drug-metabolizing enzymes, inducers or inhibitors of these enzymes may change the clearance and hence, the half-life of Ondansetron. On the basis of available data, no dosage adjustment of Ondasetron is recommended for patients on these drugs.

প্রতিনির্দেশনা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Contraindicated in patients known to have hypersensitivity to the drug or any of its components. Concomitant use of apomorphine.

পার্শ্ব প্রতিক্রিয়া

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Frequently reported adverse events were headache, constipation and diarrhea, but the majority have been mild or moderate in nature. In chemotherapy-induced nausea and vomiting, rash has occurred in approximately 1% of patients receiving Ondansetron. There also have been reports to a sensation of flushing or warmth, hiccups and liver enzyme abnormalities. Rare cases of anaphylaxis, brochospasm, tachycardia, angina (chest pain), hypokalemia, shortness of breath have also been reported, except for bronchospasm and anaphylaxis, the relationship to Ondansetron is unclear. There have been no evidence to extrapyramidal reactions, in rare case oculogyric crisis appearing alone, as well as with other dystonic reactions without definitive clinical evidence. In case of PONV, with the exception of headache, rates of these events were not significantly different in the Ondansetron and placebo groups.

গর্ভাবস্থায় ও স্তন্যদানকালে

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Carcinogenic effects were not seen in 2-year studies in rats and mice with oral Ondansetron doses up to 10 and 30 mg/kg per day, respectively. Ondansetron was not mutagenic in standard tests for mutagenicity. Oral administration of Ondansetron up to 15 mg/kg per day did not affect fertility or general reproduction performance of male and female rats.

Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.

সতর্কতা

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Hypersensitivity reactions have been reported in patients who have exhibited hypersensitivity to other selective 5-HT3 receptor antagonists. Ondansetron is not a drug that stimulates gastric or intestinal peristalsis. It should not be used instead of nasogastric suction. The use of Ondansetron in patients following abdominal surgery or in patients with chemotherapy-induced nausea and vomiting may mask a progressive ileus and/or gastric distension.

সংরক্ষণ

এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।

Store at temperature not exceeding 30ºC in a dry place. Protect from light and moisture.

বিকল্প ব্র্যান্ড: Ondansetron

একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।

Periset Suppository

16 mg

Ondansetron

The ACME Laboratories Ltd.

৳ ০.৯৮ ৳ ১ ২% ছাড় প্রতি ইউনিট

Vomitof Solution Syrup

4 mg/5 ml

Ondansetron

Chemist Laboratories Ltd.

৳ ০.৯৮ ৳ ১ ২% ছাড় প্রতি ইউনিট

Oncodex Tablet

4 mg

Ondansetron

Jayson Pharmaceuticals Ltd.

৳ ৪.৪৪ ৳ ৪.৫৩ ২% ছাড় প্রতি ইউনিট

Anset 5 mg Tablet

4 mg

Ondansetron

Opsonin Pharma Limited

৳ ৪.৪৫ ৳ ৪.৫৪ ২% ছাড় প্রতি ইউনিট

Seton Tablet

4 mg

Ondansetron

Delta Pharma Limited

৳ ৪.৯ ৳ ৫.০০ ২% ছাড় প্রতি ইউনিট

Seton Tablet

8 mg

Ondansetron

Delta Pharma Limited

৳ ৪.৯ ৳ ৫.০০ ২% ছাড় প্রতি ইউনিট

Emeren 4mg Tablet

4 mg

Ondansetron

Renata PLC.

৳ ৫.৮৮ ৳ ৬ ২% ছাড় প্রতি ইউনিট

Oncodex Tablet

8 mg

Ondansetron

Jayson Pharmaceuticals Ltd.

৳ ৭.৯ ৳ ৮.০৬ ২% ছাড় প্রতি ইউনিট

Emiteron Tablet

8 mg

Ondansetron

Premier Pharmaceuticals Ltd.

৳ ৮.৮২ ৳ ৯.০০ ২% ছাড় প্রতি ইউনিট

Onasia Tablet

8 mg

Ondansetron

Orion Pharma Ltd.

৳ ৯.৮ ৳ ১০.০০ ২% ছাড় প্রতি ইউনিট

Periset Tablet

8 mg

Ondansetron

The ACME Laboratories Ltd.

৳ ৯.৮৩ ৳ ১০.০৩ ২% ছাড় প্রতি ইউনিট

Osetron Tablet

8 mg

Ondansetron

Advanced Chemical Industries PLC

৳ ৯.৮৭ ৳ ১০.০৭ ২% ছাড় প্রতি ইউনিট

সব দেখুন ৭৪ ব্র্যান্ড

ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।